Third- and fourth-year dental students at the University at Buffalo are using tobacco counseling to encourage patients to quit. After eight hours of training, they adhere to a modified version of the '5 As' protocol, showing a 51% success rate in getting patients to quit immediately. Over six months, 32% of patients remain smoke-free.
The ABSORB trial demonstrated no stent thrombosis and a low rate of Major Adverse Cardiac Events after six months. The findings suggest that bioabsorbable drug-eluting stents may be a promising future therapy option for treating heart disease.
Researchers evaluated the safety and performance of a new bioabsorbable stent that eliminates several problems associated with metallic stents. At 30 days, device success was extremely high, and no patients experienced major adverse cardiac events or stent thrombosis.
Researchers investigate lifestyle choices and their impact on heart risks, exploring the effects of dark chocolate and nicotine patches on cardiovascular health. Studies find that flavonoids in dark chocolate can improve endothelial function in adults with BMI between 25-35 kg/m2.
New York University study reveals Homo rudolfensis had a small brain and protruding jaw, similar to Australopithecus and Paranthropus. The 1.9 million-year-old skull's features contradict the long-held depiction of modern man's earliest direct ancestor as having a vertical facial profile and large brain.
A new study attributes long-term survival rates after cardiac surgery to the rising use of cardiac drugs, including low-dose aspirin. Researchers found that lower doses of therapies may be just as beneficial while lowering side effects.
Researchers examined long-term follow-up of stents placed in infants with congenital heart disease, finding sustained benefits and the ability to safely enlarge stents as children grow. Additionally, studies investigated percutaneous pulmonary valve implantation, analyzing its mid-term outcomes and impact on device removal.
A NYU College of Dentistry research team analyzed caries and periodontal disease rates in over 1,500 immigrants from various countries. The study revealed significant ethnic differences, with Puerto Ricans, Haitians, and Indians more likely to suffer from periodontal disease, while Hispanics were more prone to dental caries.
A novel platelet therapy, SCH 530348, has demonstrated safety and efficacy in reducing percutaneous coronary intervention (PCI) complications. Major adverse events were reduced by 1.6-3.5% in low-dose cohorts compared to placebo. The treatment also showed a lower risk of death or major adverse events and heart attack compared to placebo.
A study comparing drug-eluting stents (DES) and bare-metal stents (BMS) found similar rates of complications, including stent thrombosis, MI, and mortality. However, DES patients had a slightly increased risk of stent thrombosis and heart attack between 12-15 months after implantation.
The SPIRIT-III trial shows that the Xience V Everolimus Eluting Coronary Stent System reduces target vessel failure, ischemic-driven revascularization procedures, and major adverse cardiac events compared to paclitaxel-eluting stents. This suggests a potential enhancement of outcomes for patients with coronary artery disease.